Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial. (Record no. 21335962)

MARC details
000 -LEADER
fixed length control field 01666 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516064836.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201206s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1573-7241
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s10557-011-6358-9
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nicholls, Stephen J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120626
245 00 - TITLE STATEMENT
Title Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cardiovascular drugs and therapy
Date of publication, distribution, etc. Feb 2012
300 ## - PHYSICAL DESCRIPTION
Extent 71-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acetates
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acute Coronary Syndrome
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Atorvastatin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heptanoic Acids
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydroxymethylglutaryl-CoA Reductase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inflammation
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Keto Acids
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phospholipases A2, Secretory
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cavender, Matthew A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kastelein, John J P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schwartz, Gregory
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Waters, David D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rosenson, Robert S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bash, Dianna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hislop, Colin
773 0# - HOST ITEM ENTRY
Title Cardiovascular drugs and therapy
Related parts vol. 26
-- no. 1
-- p. 71-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s10557-011-6358-9">https://doi.org/10.1007/s10557-011-6358-9</a>
Public note Available from publisher's website

No items available.